News GTAC News

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

View Content

Fluidigm said on Thursday that it has received the CE-IVD mark for its Advanta Dx SARS-CoV-2 RT-PCR assay, an extraction-free saliva-based test to detect nucleic acid from the SARS-CoV-2 virus.

Print Friendly, PDF & Email